Invention Grant
- Patent Title: Process for preparing beta 3 agonists and intermediates
-
Application No.: US17399274Application Date: 2021-08-11
-
Publication No.: US11649243B2Publication Date: 2023-05-16
- Inventor: Feng Xu , Zhuqing Liu , Richard Desmond , Jeonghan Park , Alexei Kalinin , Birgit Kosjek , Hallena Strotman , Hongmei Li , Johannah Moncecchi
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- The original application number of the division: US14776366
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D207/08 ; C07C215/30 ; C07D207/12 ; C12P17/10
Abstract:
The application is directed to efficient and economical processes as described in more detail below for the preparation of the beta 3 agonists of the formula of I-7 and intermediate compounds that can be used for making these agonists. The present disclosure relates to a process for making beta-3 agonists and intermediates using ketoreductase (KRED) biocatalyst enzymes and methods of using the biocatalysts.
Public/Granted literature
- US20220073523A1 PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES Public/Granted day:2022-03-10
Information query
